Ontological representation of CDC Active Bacterial Core Surveillance Case Reports

The Center for Disease Control and Prevention’s Active Bacterial Core Surveillance (CDC ABCs) Program is a collaborative effort betweeen the CDC, state health departments, laboratories, and universities to track invasive bacterial pathogens of particular importance to public health [1]. The year-end surveillance reports produced by this program help to shape public policy and coordinate responses to emerging infectious diseases over time. The ABCs case report form (CRF) data represents an excellent opportunity for data reuse beyond the original surveillance purposes

The Infectious Disease Ontology in the Age of COVID-19

The Infectious Disease Ontology (IDO) is a suite of interoperable ontology modules that aims to provide coverage of all aspects of the infectious disease domain, including biomedical research, clinical care, and public health. IDO Core is designed to be a disease and pathogen neutral ontology, covering just those types of entities and relations that are relevant to infectious diseases generally. IDO Core is then extended by a collection of ontology modules focusing on specific diseases and pathogens. In this paper we present applications of IDO Core within various areas of infectious disease research, together with an overview of all IDO extension ontologies and the methodology on the basis of which they are built. We also survey recent developments involving IDO, including the creation of IDO Virus; the Coronaviruses Infectious Disease Ontology (CIDO); and an extension of CIDO focused on COVID-19 (IDO-CovID-19).We also discuss how these ontologies might assist in information-driven efforts to deal with the ongoing COVID-19 pandemic, to accelerate data discovery in the early stages of future pandemics, and to promote reproducibility of infectious disease research

Doctor of Philosophy

dissertationThe use of the various complementary and alternative medicine (CAM) modalities for the management of chronic illnesses is widespread, and still on the rise. Unfortunately, tools to support consumers in seeking information on the efficacy of these treatments are sparse and incomplete. The goals of this work were to understand CAM information needs in acquiring CAM information, assess currently available information resources, and investigate informatics methods to provide a foundation for the development of CAM information resources. This dissertation consists of four studies. The first was a quantitative study that aimed to assess the feasibility of delivering CAM-drug interaction information through a web-based application. This study resulted in an 85% participation rate and 33% of those patients reported the use of CAMs that had potential interactions with their conventional treatments. The next study aimed to assess online CAM information resources that provide information on drug-herb interactions to consumers. None of the sites scored high on the combination of completeness and accuracy and all sites were beyond the recommended reading level per the US Department of Health and Human Services. The third study investigated information-seeking behaviors for CAM information using an existing cohort of cancer survivors. The study showed that patients in the cohort continued to use CAM well into survivorship. Patients felt very much on their own in dealing with issues outside of direct treatment, which often resulted in a search for options and CAM use. Finally, a study was conducted to investigate two methods to semi-automatically extract CAM treatment relations from the biomedical literature. The methods rely on a database (SemMedDB) of semantic relations extracted from PubMed abstracts. This study demonstrated that SemMedDB can be used to reduce manual efforts, but review of the extracted sentences is still necessary due to a low mean precision of 23.7% and 26.4%. In summary, this dissertation provided greater insight into consumer information needs for CAM. Our findings provide an opportunity to leverage existing resources to improve the information-seeking experience for consumers through high-quality online tools, potentially moving them beyond the reliance on anecdotal evidence in the decision-making process for CAM

Collaborative development of predictive toxicology applications

OpenTox provides an interoperable, standards-based Framework for the support of predictive toxicology data management, algorithms, modelling, validation and reporting. It is relevant to satisfying the chemical safety assessment requirements of the REACH legislation as it supports access to experimental data, (Quantitative) Structure-Activity Relationship models, and toxicological information through an integrating platform that adheres to regulatory requirements and OECD validation principles. Initial research defined the essential components of the Framework including the approach to data access, schema and management, use of controlled vocabularies and ontologies, architecture, web service and communications protocols, and selection and integration of algorithms for predictive modelling. OpenTox provides end-user oriented tools to non-computational specialists, risk assessors, and toxicological experts in addition to Application Programming Interfaces (APIs) for developers of new applications. OpenTox actively supports public standards for data representation, interfaces, vocabularies and ontologies, Open Source approaches to core platform components, and community-based collaboration approaches, so as to progress system interoperability goals

A mode-of-action ontology model for safety evaluation of chemicals: outcome of a series of workshops on repeated dose toxicity

Repeated dose toxicity evaluation aims at assessing the occurrence of adverse effects following chronic or repeated exposure to chemicals. Non-animal approaches have gained importance in the last decades because of ethical considerations as well as due to scientific reasons calling for more human-based strategies. A critical aspect of this challenge is linked to the capacity to cover a comprehensive set of interdependent mechanisms of action, link them to adverse effects and interpret their probability to be triggered in the light of the exposure at the (sub)cellular level. Inherent to its structured nature, an ontology addressing repeated dose toxicity could be a scientific and transparent way to achieve this goal. Additionally, repeated dose toxicity evaluation through the use of a harmonized ontology should be performed in a reproducible and consistent manner, while mimicking as accurately as possible human physiology and adaptivity. In this paper, the outcome of a series of workshops organized by Cosmetics Europe on this topic is reported. As such, this manuscript shows how experts set critical elements and ways of establishing a mode-of-action ontology model as a support to risk assessors aiming to perform animal-free safety evaluation of chemicals based on repeated dose toxicity data